MEDICAL AIR, USP (air) by Connect Biopharma. Approved for asthma, chronic obstructive pulmonary disease. First approved in 2013.
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
MEDICAL AIR, USP is a pharmaceutical-grade gaseous product approved for inhalation in asthma and chronic obstructive pulmonary disease (COPD). The product operates through simple respiratory gas delivery with no active pharmacological mechanism of action. It represents a commodity-like therapeutic category in respiratory care.
Product is at peak lifecycle but faces significant commoditization pressure; team growth opportunities are limited given low competitive differentiation and lack of active pharmacology.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Tapestry Rotator Cuff Repair PMCF
Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function
Decellularized Human Placental Extracellular Matrix Tissue for Rotator Cuff Repair Augmentation
Study of Protection And Repair of Endothelial-glycocalyx in Sepsis (SPARES)
Mitral Valve Repair With the Chord-X System: A Long Term Evaluation
Worked on MEDICAL AIR, USP at Connect Biopharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Connect Biopharma is hiring 1 role related to this product
Working on MEDICAL AIR offers limited career acceleration due to zero linked job postings, mature lifecycle, and absence of differentiation versus generic medical gas suppliers. Roles are primarily transactional and commoditized rather than strategic brand-building positions.